In addition, previous researches have identified the glucose-to-mannose ratio as a risk factor for HER2-positive breast cancer, and its level in serum shows promise as a potential biomarker for ovarian cancer [44], implying its potential as an early diagnostic biomarker. This evidence concerns the gene ERBB2 and ovarian carcinoma.